Jazz Pharmaceuticals Company Profile

Aggregated data from the web about Jazz Pharmaceuticals

Company Name	Jazz Pharmaceuticals
Website	https://www.jazzpharma.com
Snippet	Jazz Pharmaceuticals is a global biopharmaceutical company dedicated to bringing life-changing medicines to people with limited or no options, so they can live their lives more fully. More About Jazz Living Our Values Careers at Jazz Clinical Trials Learn More
Type	Public
Brands	Xyrem, Erwinaze, Defitelio, FazaClo, FazaClo HD, Luvox CR, Prialt, Vyxeos
Founded	2005
Revenue	US$1.618 billion (2017)[1]
Website	www.jazzpharma.com
Industry	BiotechnologyPharmaceutical
Products	Pharmaceutical drugs
Traded as	NASDAQ: JAZZRussell 1000 Index component
Key people	Bruce C. Cozadd, Chairman & CEO
Net income	US$487.8 million (2017)[1]
Area served	Worldwide
Predecessor	Jazz Pharmaceuticals, Inc. (before the 2012 tax inversion to Ireland)
Headquarters	Waterloo Exchange, Waterloo Road, D04 E5W7, Dublin, Ireland
Total assets	US$5.123 billion (2017)[1]
Total equity	US$2.713 billion (2017)[1]
Operating income	US$528.8 million (2017)[1]
Number of employees	~1,210 (February 2018)[1]

Jazz Pharmaceuticals is part of the Ireland company list

Jazz Pharmaceuticals is part of the Biotechnology company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.